Global Pediatric Drugs and Vaccines Sales Market Report 2021

1 Pediatric Drugs and Vaccines Market Overview
    1.1 Pediatric Drugs and Vaccines Product Scope
    1.2 Pediatric Drugs and Vaccines Segment by Type
        1.2.1 Global Pediatric Drugs and Vaccines Sales by Type (2016 & 2021 & 2027)
        1.2.2 Diphtheria
        1.2.3 Influenza
        1.2.4 Hepatitis
        1.2.5 Pneumococcal Diseases
        1.2.6 Meningococcal Diseases
        1.2.7 Mumps
        1.2.8 Others
    1.3 Pediatric Drugs and Vaccines Segment by Application
        1.3.1 Global Pediatric Drugs and Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Newborn
        1.3.3 Infant
        1.3.4 Child
    1.4 Pediatric Drugs and Vaccines Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Pediatric Drugs and Vaccines Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Pediatric Drugs and Vaccines Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Pediatric Drugs and Vaccines Price Trends (2016-2027)

2 Pediatric Drugs and Vaccines Estimates and Forecasts by Region
    2.1 Global Pediatric Drugs and Vaccines Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Pediatric Drugs and Vaccines Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2021)
        2.2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2016-2021)
    2.3 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Pediatric Drugs and Vaccines Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
        2.4.2 Europe Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
        2.4.3 China Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
        2.4.4 Japan Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)
        2.4.6 India Pediatric Drugs and Vaccines Estimates and Projections (2016-2027)

3 Global Pediatric Drugs and Vaccines Competition Landscape by Players
    3.1 Global Top Pediatric Drugs and Vaccines Players by Sales (2016-2021)
    3.2 Global Top Pediatric Drugs and Vaccines Players by Revenue (2016-2021)
    3.3 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Drugs and Vaccines as of 2020)
    3.4 Global Pediatric Drugs and Vaccines Average Price by Company (2016-2021)
    3.5 Manufacturers Pediatric Drugs and Vaccines Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Pediatric Drugs and Vaccines Market Size by Type
    4.1 Global Pediatric Drugs and Vaccines Historic Market Review by Type (2016-2021)
        4.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
        4.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021)
        4.1.3 Global Pediatric Drugs and Vaccines Price by Type (2016-2021)
    4.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Type (2022-2027)
        4.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2022-2027)
        4.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Type (2022-2027)

5 Global Pediatric Drugs and Vaccines Market Size by Application
    5.1 Global Pediatric Drugs and Vaccines Historic Market Review by Application (2016-2021)
        5.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
        5.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2016-2021)
        5.1.3 Global Pediatric Drugs and Vaccines Price by Application (2016-2021)
    5.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Application (2022-2027)
        5.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2022-2027)
        5.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Application (2022-2027)

6 North America Pediatric Drugs and Vaccines Market Facts & Figures
    6.1 North America Pediatric Drugs and Vaccines Sales by Company
        6.1.1 North America Pediatric Drugs and Vaccines Sales by Company (2016-2021)
        6.1.2 North America Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
    6.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Type
        6.2.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
        6.2.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
    6.3 North America Pediatric Drugs and Vaccines Sales Breakdown by Application
        6.3.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Application (2016-2021)
        6.3.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Application (2022-2027)

7 Europe Pediatric Drugs and Vaccines Market Facts & Figures
    7.1 Europe Pediatric Drugs and Vaccines Sales by Company
        7.1.1 Europe Pediatric Drugs and Vaccines Sales by Company (2016-2021)
        7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
    7.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type
        7.2.1 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
    7.3 Europe Pediatric Drugs and Vaccines Sales Breakdown by Application
        7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)

8 China Pediatric Drugs and Vaccines Market Facts & Figures
    8.1 China Pediatric Drugs and Vaccines Sales by Company
        8.1.1 China Pediatric Drugs and Vaccines Sales by Company (2016-2021)
        8.1.2 China Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
    8.2 China Pediatric Drugs and Vaccines Sales Breakdown by Type
        8.2.1 China Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
        8.2.2 China Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
    8.3 China Pediatric Drugs and Vaccines Sales Breakdown by Application
        8.3.1 China 163 Sales Breakdown by Application (2016-2021)
        8.3.2 China 163 Sales Breakdown by Application (2022-2027)

9 Japan Pediatric Drugs and Vaccines Market Facts & Figures
    9.1 Japan Pediatric Drugs and Vaccines Sales by Company
        9.1.1 Japan Pediatric Drugs and Vaccines Sales by Company (2016-2021)
        9.1.2 Japan Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
    9.2 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type
        9.2.1 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
    9.3 Japan Pediatric Drugs and Vaccines Sales Breakdown by Application
        9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Pediatric Drugs and Vaccines Market Facts & Figures
    10.1 Southeast Asia Pediatric Drugs and Vaccines Sales by Company
        10.1.1 Southeast Asia Pediatric Drugs and Vaccines Sales by Company (2016-2021)
        10.1.2 Southeast Asia Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
    10.2 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type
        10.2.1 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Application
        10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)

11 India Pediatric Drugs and Vaccines Market Facts & Figures
    11.1 India Pediatric Drugs and Vaccines Sales by Company
        11.1.1 India Pediatric Drugs and Vaccines Sales by Company (2016-2021)
        11.1.2 India Pediatric Drugs and Vaccines Revenue by Company (2016-2021)
    11.2 India Pediatric Drugs and Vaccines Sales Breakdown by Type
        11.2.1 India Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021)
        11.2.2 India Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027)
    11.3 India Pediatric Drugs and Vaccines Sales Breakdown by Application
        11.3.1 India Pediatric Drugs and Vaccines Sales Breakdown by Application (2016-2021)
        11.3.2 India Pediatric Drugs and Vaccines Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Pediatric Drugs and Vaccines Business
    12.1 Merck & Co., Inc. (USA)
        12.1.1 Merck & Co., Inc. (USA) Corporation Information
        12.1.2 Merck & Co., Inc. (USA) Business Overview
        12.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
        12.1.5 Merck & Co., Inc. (USA) Recent Development
    12.2 Abbott Laboratories (USA)
        12.2.1 Abbott Laboratories (USA) Corporation Information
        12.2.2 Abbott Laboratories (USA) Business Overview
        12.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products Offered
        12.2.5 Abbott Laboratories (USA) Recent Development
    12.3 Amgen, Inc. (USA)
        12.3.1 Amgen, Inc. (USA) Corporation Information
        12.3.2 Amgen, Inc. (USA) Business Overview
        12.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
        12.3.5 Amgen, Inc. (USA) Recent Development
    12.4 Eli Lilly and Company (USA)
        12.4.1 Eli Lilly and Company (USA) Corporation Information
        12.4.2 Eli Lilly and Company (USA) Business Overview
        12.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products Offered
        12.4.5 Eli Lilly and Company (USA) Recent Development
    12.5 F. Hoffmann-La Roche Ltd (Switzerland)
        12.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
        12.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
        12.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products Offered
        12.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
    12.6 Genentech, Inc. (USA)
        12.6.1 Genentech, Inc. (USA) Corporation Information
        12.6.2 Genentech, Inc. (USA) Business Overview
        12.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
        12.6.5 Genentech, Inc. (USA) Recent Development
    12.7 GlaxoSmithKline plc. (UK)
        12.7.1 GlaxoSmithKline plc. (UK) Corporation Information
        12.7.2 GlaxoSmithKline plc. (UK) Business Overview
        12.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products Offered
        12.7.5 GlaxoSmithKline plc. (UK) Recent Development
    12.8 Janssen Biologics B.V. (USA)
        12.8.1 Janssen Biologics B.V. (USA) Corporation Information
        12.8.2 Janssen Biologics B.V. (USA) Business Overview
        12.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products Offered
        12.8.5 Janssen Biologics B.V. (USA) Recent Development
    12.9 Actelion Pharmaceuticals
        12.9.1 Actelion Pharmaceuticals Corporation Information
        12.9.2 Actelion Pharmaceuticals Business Overview
        12.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products Offered
        12.9.5 Actelion Pharmaceuticals Recent Development
    12.10 AstraZeneca Plc. (UK)
        12.10.1 AstraZeneca Plc. (UK) Corporation Information
        12.10.2 AstraZeneca Plc. (UK) Business Overview
        12.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products Offered
        12.10.5 AstraZeneca Plc. (UK) Recent Development
    12.11 Boehringer Ingelheim GmbH (Germany)
        12.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
        12.11.2 Boehringer Ingelheim GmbH (Germany) Business Overview
        12.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Products Offered
        12.11.5 Boehringer Ingelheim GmbH (Germany) Recent Development
    12.12 Bristol-Myers Squibb Company (USA)
        12.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
        12.12.2 Bristol-Myers Squibb Company (USA) Business Overview
        12.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Products Offered
        12.12.5 Bristol-Myers Squibb Company (USA) Recent Development
    12.13 Allergan, Inc. (USA)
        12.13.1 Allergan, Inc. (USA) Corporation Information
        12.13.2 Allergan, Inc. (USA) Business Overview
        12.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
        12.13.5 Allergan, Inc. (USA) Recent Development
    12.14 Novartis AG (Switzerland)
        12.14.1 Novartis AG (Switzerland) Corporation Information
        12.14.2 Novartis AG (Switzerland) Business Overview
        12.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Products Offered
        12.14.5 Novartis AG (Switzerland) Recent Development
    12.15 Novo Nordisk A/S (Denmark)
        12.15.1 Novo Nordisk A/S (Denmark) Corporation Information
        12.15.2 Novo Nordisk A/S (Denmark) Business Overview
        12.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Products Offered
        12.15.5 Novo Nordisk A/S (Denmark) Recent Development
    12.16 Pfizer, Inc. (USA)
        12.16.1 Pfizer, Inc. (USA) Corporation Information
        12.16.2 Pfizer, Inc. (USA) Business Overview
        12.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
        12.16.5 Pfizer, Inc. (USA) Recent Development
    12.17 Sanofi S.A (France)
        12.17.1 Sanofi S.A (France) Corporation Information
        12.17.2 Sanofi S.A (France) Business Overview
        12.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Products Offered
        12.17.5 Sanofi S.A (France) Recent Development
    12.18 Shionogi Inc. (USA)
        12.18.1 Shionogi Inc. (USA) Corporation Information
        12.18.2 Shionogi Inc. (USA) Business Overview
        12.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Products Offered
        12.18.5 Shionogi Inc. (USA) Recent Development
    12.19 Takeda
        12.19.1 Takeda Corporation Information
        12.19.2 Takeda Business Overview
        12.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
        12.19.4 Takeda Pediatric Drugs and Vaccines Products Offered
        12.19.5 Takeda Recent Development

13 Pediatric Drugs and Vaccines Manufacturing Cost Analysis
    13.1 Pediatric Drugs and Vaccines Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines
    13.4 Pediatric Drugs and Vaccines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Pediatric Drugs and Vaccines Distributors List
    14.3 Pediatric Drugs and Vaccines Customers

15 Market Dynamics
    15.1 Pediatric Drugs and Vaccines Market Trends
    15.2 Pediatric Drugs and Vaccines Drivers
    15.3 Pediatric Drugs and Vaccines Market Challenges
    15.4 Pediatric Drugs and Vaccines Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer